SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Klarissa Siebenhuener, Emmanuel Eschmann, Alexander Kienast, Dominik Schneider, Christoph E. Minder, Reinhard Saller, Lukas Zimmerli, Jürg Blaser, Edouard Battegay, Barbara M. Holzer, Claudia Sommer, Chronic Pain: How Challenging Are DDIs in the Analgesic Treatment of Inpatients with Multiple Chronic Conditions?, PLOS ONE, 2017, 12, 1, e0168987

    CrossRef

  2. 2
    Ghulam Murtaza, Muhammad Yasir Ghani Khan, Saira Azhar, Shujaat Ali Khan, Tahir M. Khan, Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patients, Saudi Pharmaceutical Journal, 2016, 24, 2, 220

    CrossRef

  3. 3
    M. B. Lebowitz, K. L. Olson, M. Burns, M. B. Harper, F. Bourgeois, Drug-Drug Interactions Among Hospitalized Children Receiving Chronic Antiepileptic Drug Therapy, Hospital Pediatrics, 2016, 6, 5, 282

    CrossRef

  4. 4
    Dae Hyun Kim, Michael W. Rich, Patient-Centred Care of Older Adults With Cardiovascular Disease and Multiple Chronic Conditions, Canadian Journal of Cardiology, 2016, 32, 9, 1097

    CrossRef

  5. 5
    Fantaye Teka, Gebrehiwot Teklay, Eskindeir Ayalew, Terefe Teshome, Potential drug–drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study, BMC Research Notes, 2016, 9, 1

    CrossRef

  6. 6
    Mariko Teramura-Grönblad, Minna Raivio, Niina Savikko, Seija Muurinen, Helena Soini, Merja Suominen, Kaisu Pitkälä, Potentially severe drug–drug interactions among older people and associations in assisted living facilities in Finland: a cross-sectional study, Scandinavian Journal of Primary Health Care, 2016, 34, 3, 250

    CrossRef

  7. 7
    Emanuel Raschi, Carlo Piccinni, Vincenzo Signoretta, Lucio Lionello, Silvia Bonezzi, Marcello Delfino, Lucia Di Candia, Lucio Di Castri, Fabio Pieraccini, Daniela Carati, Elisabetta Poluzzi, Fabrizio De Ponti, Clinically important drug–drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice, British Journal of Clinical Pharmacology, 2015, 80, 6
  8. 8
    Bruce Guthrie, Boikanyo Makubate, Virginia Hernandez-Santiago, Tobias Dreischulte, The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010, BMC Medicine, 2015, 13, 1

    CrossRef

  9. 9
    Stefania Antoniazzi, Maria Teresa Chiarelli, Alessandro Nobili, Luca Pasina, Francesca Venturini, The value of software that provides clinically relevant information on drug interactions, European Journal of Internal Medicine, 2015, 26, 9, e52

    CrossRef

  10. 10
    Fermín García-Gollarte, José Baleriola-Júlvez, Isabel Ferrero-López, Álvaro Cuenllas-Díaz, Alfonso J. Cruz-Jentoft, An Educational Intervention on Drug Use in Nursing Homes Improves Health Outcomes Resource Utilization and Reduces Inappropriate Drug Prescription, Journal of the American Medical Directors Association, 2014, 15, 12, 885

    CrossRef

  11. 11
    Silvio Garattini, Norberto Perico, Drug development: how academia, industry and authorities interact, Nature Reviews Nephrology, 2014, 10, 10, 602

    CrossRef

  12. 12
    Sylvie D. Price, C. D’Arcy J. Holman, Frank M. Sanfilippo, Jon D. Emery, Impact of Specific Beers Criteria Medications on Associations between Drug Exposure and Unplanned Hospitalisation in Elderly Patients Taking High-Risk Drugs: A Case-Time-Control Study in Western Australia, Drugs & Aging, 2014, 31, 4, 311

    CrossRef

  13. 13
    Bozana Nikolic, Slobodan Jankovic, Oliver Stojanov, Jovan Popovic, Prevalence and predictors of potential drug-drug interactions, Open Medicine, 2014, 9, 2

    CrossRef

  14. 14
    A. Marengoni, L. Pasina, C. Concoreggi, G. Martini, F. Brognoli, A. Nobili, G. Onder, D. Bettoni, Understanding adverse drug reactions in older adults through drug–drug interactions, European Journal of Internal Medicine, 2014, 25, 9, 843

    CrossRef

  15. 15
    Danijela Gnjidic, Kristina Johnell, Clinical implications from drug–drug and drug–disease interactions in older people, Clinical and Experimental Pharmacology and Physiology, 2013, 40, 5
  16. 16
    Luca Pasina, Codjo D. Djade, Alessandro Nobili, Mauro Tettamanti, Carlotta Franchi, Francesco Salerno, Salvatore Corrao, Alessandra Marengoni, Alfonso Iorio, Maura Marcucci, PierMannuccio Mannucci, Drug–drug interactions in a cohort of hospitalized elderly patients, Pharmacoepidemiology and Drug Safety, 2013, 22, 10
  17. 17
    Cheng Kin Lao, Sao Chan Ho, Ka Kit Chan, Chon Fai Tou, Henry Hoi Yee Tong, Alexandre Chan, Potentially inappropriate prescribing and drug–drug interactions among elderly Chinese nursing home residents in Macao, International Journal of Clinical Pharmacy, 2013, 35, 5, 805

    CrossRef

  18. 18
    Simona Ghibelli, Alessandra Marengoni, Codjo D. Djade, Alessandro Nobili, Mauro Tettamanti, Carlotta Franchi, Silvio Caccia, Flavio Giovarruscio, Andrea Remuzzi, Luca Pasina, Prevention of Inappropriate Prescribing in Hospitalized Older Patients Using a Computerized Prescription Support System (INTERcheck®), Drugs & Aging, 2013, 30, 10, 821

    CrossRef

  19. You have free access to this content19
    Guiding Principles for the Care of Older Adults with Multimorbidity: An Approach for Clinicians, Journal of the American Geriatrics Society, 2012, 60, 10
  20. 20
    Roschelle Heuberger, Polypharmacy and Food–Drug Interactions Among Older Persons: A Review, Journal of Nutrition in Gerontology and Geriatrics, 2012, 31, 4, 325

    CrossRef

  21. 21
    Yu Ko, Sze-Ling Daphne Tan, Alexandre Chan, Yuet-Peng Wong, Wei-Peng Yong, Raymond Chee-Hui Ng, Siew-Woon Lim, Agus Salim, Prevalence of the Coprescription of Clinically Important Interacting Drug Combinations Involving Oral Anticancer Agents in Singapore: A Retrospective Database Study, Clinical Therapeutics, 2012, 34, 8, 1696

    CrossRef

  22. 22
    Bruce W. Bode, Jason Brett, Ali Falahati, Richard E. Pratley, Comparison of the Efficacy and Tolerability Profile of Liraglutide, a Once-Daily Human GLP-1 Analog, in Patients With Type 2 Diabetes ≥65 and <65 Years of Age: A Pooled Analysis from Phase III Studies, The American Journal of Geriatric Pharmacotherapy, 2011, 9, 6, 423

    CrossRef

  23. 23
    Antonio Sacchetta, Pietro Marino, Policronicità e politerapia in fase cronica e di riacutizzazione, Italian Journal of Medicine, 2011, 5, 1, 179

    CrossRef

  24. 24
    Chen-Fang Lin, Chun-Yu Wang, Chyi-Huey Bai, Polypharmacy, Aging and Potential Drug-Drug Interactions in Outpatients in Taiwan, Drugs & Aging, 2011, 28, 3, 219

    CrossRef

  25. 25
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2010, 19, 2
  26. 26
    Sven Stegemann, Felix Ecker, Mario Maio, Peter Kraahs, Rainer Wohlfart, Joerg Breitkreutz, Andreas Zimmer, Daniel Bar-Shalom, Patrick Hettrich, Bianca Broegmann, Geriatric drug therapy: Neglecting the inevitable majority, Ageing Research Reviews, 2010, 9, 4, 384

    CrossRef

  27. 27
    Nina Fokter, Martin Možina, Miran Brvar, Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments, Wiener klinische Wochenschrift, 2010, 122, 3-4, 81

    CrossRef

  28. 28
    Elizabeth E. Roughead, Lisa M. Kalisch, John D. Barratt, Andrew L. Gilbert, Prevalence of potentially hazardous drug interactions amongst Australian veterans, British Journal of Clinical Pharmacology, 2010, 70, 2
  29. 29
    Francesco Lapi, Claudia Pozzi, Giampiero Mazzaglia, Andrea Ungar, Stefano Fumagalli, Niccolò Marchionni, Pierangelo Geppetti, Alessandro Mugelli, Mauro Di Bari, Epidemiology of Suboptimal Prescribing in Older, Community Dwellers, Drugs & Aging, 2009, 26, 12, 1029

    CrossRef